Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive Insulin vs Oral Agents in Newly Diagnosed T2DM
NCT00147836Phase 4Completed
- Sponsor
- Sun Yat-sen University
- Start
- Sep 2004
- Primary completion
- Oct 2007
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of regular human insulin, gliclazide and metformin in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Sun Yat-sen University. Primary endpoints: Diabetes Remission Rate at 1 year, Beta-cell Function Indices at 1 year and 1 more. Started Sep 2004; status: completed.
02
Drugs
regular human insulingliclazidemetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00147836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00147836.